Aspiro Pharma Specialities Private Limited
About Aspiro Pharma Specialities Private Limited
Data last updated:
Aspiro Pharma Specialities Private Limited was a private limited company based in Gujvail, Telangana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 August 2020.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2020PTC143320. Its GSTIN is 36ABECS3132P1Z1 (Telangana).
The company had an authorised share capital of ₹55 Cr and a paid-up capital of ₹55 Cr. It was led by directors Bhavesh Bansidhar Pujara and Mahesh Ramappa Kamalamma Hassan.
Its last annual general meeting (AGM) was held on 24 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at 284 Biotech Park, Gujvail, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.9 Lakh, a decline of 46% compared to the previous year. For the same year it recorded a net loss of ₹17.9 Lakh (net margin -259.4%) and EBITDA of -₹21.7 Lakh (EBITDA margin -314.5%). Revenue has grown at a compounded annual rate (CAGR) of 96% over three years.
As per MCA filings, the company had open charges of ₹25 Cr and satisfied charges of ₹25 Cr on record.
Company details
Contact details
Aspiro Pharma Specialities Private Limited's registered office is in Gujvail, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. S – 1 S – 6 & S – 2B Survey No. 321 & 284 Biotech Park Phase – III, Karakapatla Vill Markook Mandal Siddipet Dist, Gujvail, Telangana, India – 502281
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aspiro Pharma Specialities Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aspiro Pharma Specialities Private Limited
FY 2025 filings availableAspiro Pharma Specialities Private Limited reported revenue of ₹6.9 Lakh (down 46% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 46% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 96%. EBITDA fell 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹21.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹17.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -314.5% | ||||
| Net Profit Margin | -259.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aspiro Pharma Specialities Private Limited, buy the company report.
Board of directors of Aspiro Pharma Specialities Private Limited
Aspiro Pharma Specialities has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhavesh Bansidhar Pujara | Director | 13 Nov 2024 | 1 Years 11 Months | As last reported |
| Mahesh Ramappa Kamalamma Hassan Also directs: Aspiro Pharma Limited, Annora Pharma Private Limited | Director | 13 Nov 2024 | 1 Years 11 Months | As last reported |
Auditor
Aspiro Pharma Specialities Private Limited is audited by SREELATA AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SREELATA AND ASSOCIATES | FY 2023 | 011496S |
Shareholding
The shareholding of Aspiro Pharma Specialities Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aspiro Pharma Specialities Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jun 2022 | 100593128 | State Bank of India | ₹25 Cr | Satisfied |
To see the full charge records of Aspiro Pharma Specialities Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Aspiro Pharma Specialities Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aspiro Pharma Specialities Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aspiro Pharma Specialities Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Aspiro Pharma Specialities has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABECS3132P1Z1 | Telangana | Active | 17 Dec 2020 |
To see the full GST registrations and return filing status of Aspiro Pharma Specialities Private Limited, buy the company report.
Recent activity
Aspiro Pharma Specialities Private Limited has 7 board changes on record since 2024: 2 appointments and 5 cessations. The latest: Bhavesh Bansidhar Pujara ceased to be Additional Director on 23 Jul 2025.
Frequently asked questions
Aspiro Pharma Specialities has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Aspiro Pharma Specialities was a private limited company based in Gujvail, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 29 August 2020 and is registered under CIN U24299TG2020PTC143320. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Aspiro Pharma Specialities was incorporated on 29 August 2020. It is registered with the Registrar of Companies, Hyderabad.
Aspiro Pharma Specialities had 2 directors:
- Bhavesh Bansidhar Pujara - Director
- Mahesh Ramappa Kamalamma Hassan - Director
The CIN (Corporate Identification Number) of Aspiro Pharma Specialities is U24299TG2020PTC143320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Aspiro Pharma Specialities is at Plot No. S – 1 S – 6 & S – 2B Survey No. 321 & 284 Biotech Park Phase – III, Karakapatla Vill Markook Mandal Siddipet Dist, Gujvail, Telangana, India – 502281.
The latest financial statements of Aspiro Pharma Specialities on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 July 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Aspiro Pharma Specialities is 36ABECS3132P1Z1, registered in Telangana.
Aspiro Pharma Specialities operated in the pharma industry, in the drug formulation and development segment.
Bhavesh Bansidhar Pujara ceased to be Additional Director on 23 Jul 2025. Chandra Sekhar Tumuluru ceased to be Additional Director on 23 Jul 2025. Mahesh Ramappa Kamalamma Hassan ceased to be Additional Director on 23 Jul 2025. Aspiro Pharma Specialities has 7 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
